Intake Forms for Radiology and Imaging Centers: Contrast Screening, Implant Safety, and Exam-Specific Preparation
A radiology department is one of the few clinical settings where a paperwork failure can produce a catastrophic outcome within minutes. A patient with an undisclosed cardiac pacemaker walks into a 3-Tesla MRI suite, and the device's lead tip heats to the point of myocardial burn. A patient with an unreported iodine allergy receives iodinated contrast for a CT angiogram and goes into anaphylaxis on the table. A woman in her first trimester undergoes a fluoroscopic study because nobody asked the pregnancy question. These are not theoretical scenarios drawn from risk-management seminars. They are the kinds of events that show up in malpractice filings and FDA adverse event databases every year, and in nearly every case, the root cause traces back to something that should have been captured on an intake form and was not.
Radiology intake is fundamentally different from the intake process in most other healthcare settings because the risks are immediate and physical. A primary care office that misses a medication on intake may produce a prescribing error that manifests over days or weeks. An imaging center that misses an implant on intake may produce a life-threatening injury in the next forty-five minutes. The margin for error is measured in the time between the waiting room and the bore of the magnet, and the intake form is the only systematic barrier between the patient and that risk.
What follows is a detailed examination of what a radiology and imaging center intake form needs to capture, why each section exists, and what happens operationally when any of these elements is missing or incomplete.
MRI safety screening: the most consequential section on any medical intake form
The MRI safety questionnaire is arguably the single highest-stakes intake document in all of clinical medicine. No other screening form carries the same combination of immediate physical danger and binary pass-fail consequence. If the screening misses a ferromagnetic implant, the patient enters a powerful magnetic field that cannot be turned off quickly, and the implant may torque, migrate, or heat with results ranging from severe pain to death. The ACR Guidance Document for Safe MR Practices has been updated repeatedly since its first publication precisely because incidents keep occurring, and the common denominator is almost always a screening failure.
The form needs to capture every category of implanted device and foreign body that could interact with the static magnetic field, the gradient fields, or the radiofrequency energy of the MRI system. Cardiac implantable electronic devices represent the most critical category. Patients with pacemakers and implantable cardioverter-defibrillators must be identified and their devices classified as MR-Unsafe, MR-Conditional, or MR-Safe under the ASTM labeling system before they come anywhere near Zone IV. An MR-Conditional pacemaker can be scanned, but only under specific conditions documented by the device manufacturer: field strength limits, specific absorption rate limits, gradient slew rate limits, and often a requirement that the device be reprogrammed into MRI mode by a cardiologist or device representative before the scan and restored to normal programming afterward. Your intake form must capture not just whether the patient has a pacemaker, but the manufacturer, model number, and implant date, so your MRI safety officer can verify the conditional status and determine whether your specific scanner meets the conditions.
Cochlear implants present a similar conditional-versus-unsafe distinction. Older cochlear implant models are MR-Unsafe at any field strength. Newer models from manufacturers like Cochlear, MED-EL, and Advanced Bionics are MR-Conditional at 1.5T with specific positioning requirements, and some are now conditional at 3T. The intake form must capture the implant manufacturer and model so the technologist can look up the specific conditions. A patient who says "I have a cochlear implant" without providing the model is not cleared for scanning until that information is obtained, even if it means calling the implanting surgeon's office and delaying the exam.
Beyond cardiac devices and cochlear implants, the MRI screening questionnaire must systematically address neurostimulators and deep brain stimulators, spinal cord stimulators, aneurysm clips (particularly intracranial clips, where the distinction between ferromagnetic and non-ferromagnetic is literally life and death), metallic heart valves, vascular stents and filters (IVC filters placed within the last six weeks may not yet be endothelialized and could migrate), orthopedic hardware (generally safe but may cause artifact and localized heating), penile implants, tissue expanders with magnetic ports, programmable shunt valves (which can be reset by the magnetic field), insulin pumps, continuous glucose monitors, and any other electronically, magnetically, or mechanically activated implant.
Then there is the category that patients rarely think to disclose: metallic foreign bodies. Patients with a history of working in machine shops, grinding, welding, or military service may have retained metallic fragments in soft tissue that they have long forgotten about. An orbital metallic foreign body is the classic dangerous scenario because even a tiny ferromagnetic fragment near the eye can move in the magnetic field and lacerate the globe. Many radiology departments require an orbital X-ray for any patient who reports a history of metalwork or grinding and cannot definitively state that their eyes were protected. Your intake form should ask specifically about occupational history involving metalwork, not just "do you have any metal in your body," because patients do not think of a thirty-year-old grinding fragment as "metal in their body."
Contrast media screening: renal function, allergy history, and medication interactions
Contrast-enhanced imaging studies introduce pharmacological agents into the patient's body, and those agents carry their own risk profiles that must be screened before administration. The screening requirements differ depending on whether the study uses iodinated contrast (for CT and fluoroscopy) or gadolinium-based contrast agents (for MRI), but both require structured intake documentation.
For iodinated contrast, the critical screening elements are allergy history and renal function. Patients with a documented history of prior contrast reaction need to be identified before they arrive in the CT suite so that premedication protocols can be initiated. The standard premedication regimen for patients with prior iodinated contrast reactions involves oral corticosteroids given thirteen hours and one hour before the study, plus diphenhydramine one hour before. That thirteen-hour lead time means your intake process must identify these patients well before the day of the study if possible, or at minimum early enough on the day of the study that the abbreviated five-hour emergency premedication protocol can be completed. A form that captures contrast allergy history only when the patient is already gowned and waiting in the CT room has failed at its fundamental purpose.
The form should capture not just whether the patient has had a prior contrast reaction, but the nature of the reaction. A patient who experienced mild nausea or a few hives has a very different risk profile than a patient who experienced laryngeal edema or cardiovascular collapse. The severity of the prior reaction guides the radiologist's decision about whether to proceed with premedication, switch to a different contrast agent, use CO2 as an alternative in angiographic procedures, or perform the study without contrast entirely. Recording the specific contrast agent that caused the reaction is also valuable, because reactions are sometimes agent-specific rather than class-wide, and switching from an ionic high-osmolality agent to a non-ionic low-osmolality agent may be sufficient.
Renal function screening is mandatory before iodinated contrast administration because contrast-induced nephropathy, while less common with modern low-osmolality agents than was once feared, remains a real risk in patients with pre-existing renal impairment. Most radiology departments require a serum creatinine or estimated glomerular filtration rate within thirty to ninety days of the study for patients with risk factors: age over sixty, diabetes, known renal disease, hypertension, history of renal surgery or solitary kidney, and concurrent nephrotoxic medications. Your intake form needs to capture these risk factors so that the technologist and radiologist can determine whether lab work is needed before proceeding. The form should also ask specifically about metformin use, because metformin must be held for forty-eight hours after iodinated contrast administration in patients with an eGFR below 30 to prevent the rare but serious complication of metformin-associated lactic acidosis.
For gadolinium-based contrast agents used in MRI, the primary screening concern is nephrogenic systemic fibrosis, a devastating and potentially fatal fibrotic condition that occurs almost exclusively in patients with severely impaired renal function. NSF is associated with certain linear gadolinium agents and is vanishingly rare with the macrocyclic agents that most departments now use preferentially, but the screening requirement remains. Patients with an eGFR below 30, patients on dialysis, and patients with acute kidney injury must be identified before gadolinium administration so the radiologist can evaluate the risk-benefit ratio and choose the safest available agent. Your intake form should capture known kidney disease, dialysis status, and whether the patient has had recent lab work assessing renal function.
Pregnancy screening: a non-negotiable gate for any ionizing radiation study
Every radiology department must have a systematic process for identifying pregnancy before any study that involves ionizing radiation, and that process begins on the intake form. The consequences of fetal radiation exposure are well-documented and dose-dependent: deterministic effects including growth restriction, microcephaly, and intellectual disability at higher doses, and a stochastic increase in childhood cancer risk at lower doses. No imaging study is worth these risks unless the clinical indication is urgent enough to justify them, and that risk-benefit analysis can only happen if the pregnancy is known.
The intake form should ask every female patient of childbearing age, typically defined as ages ten through fifty-five though department policies vary, about the possibility of pregnancy. The question must be direct and unambiguous. Forms that ask "are you pregnant?" miss patients who do not yet know they are pregnant. The better formulation asks about the date of the last menstrual period and whether there is any possibility of pregnancy, including patients who are actively trying to conceive or who have had unprotected intercourse since their last period. Some departments require a urine or serum pregnancy test for all women of childbearing age before any study involving ionizing radiation, regardless of the patient's answer on the form. Others use the form response as a triage tool, testing only when the answer is uncertain.
For MRI, pregnancy does not present a radiation risk, but the ACR recommends that MRI be used only when the information cannot be obtained by other non-ionizing means, and gadolinium contrast is generally avoided in pregnancy because gadolinium crosses the placenta and its effects on the developing fetus are not fully characterized. Your MRI intake form should still capture pregnancy status so the radiologist can make an informed decision about whether to proceed, whether to modify the protocol, and whether contrast should be withheld.
For nuclear medicine studies, the pregnancy question carries additional weight because radiopharmaceuticals distribute systemically and may concentrate in fetal tissues depending on the agent. Radioiodine, used in thyroid imaging and therapy, crosses the placenta and is concentrated by the fetal thyroid after approximately twelve weeks of gestation, with the potential to cause fetal hypothyroidism or thyroid ablation. Pregnancy is an absolute contraindication to radioiodine administration, and your intake documentation must reflect this with appropriate screening.
Prior imaging history and radiation dose tracking
Radiology intake forms should capture the patient's recent imaging history for two distinct reasons: avoiding unnecessary duplicate studies and monitoring cumulative radiation exposure. Both concerns have become more prominent as imaging utilization has increased and as awareness of cumulative dose effects has grown.
Duplicate imaging is a persistent problem in radiology, driven by fragmented health records, patients who visit multiple facilities, and referring physicians who order studies without checking whether a recent comparable exam already exists. A patient who had a CT of the chest at an emergency department two days ago may show up at your outpatient center with a new order for essentially the same study from their pulmonologist. If your intake form captures recent imaging history, including the type of study, body part, facility, and approximate date, the radiologist can review the prior study before exposing the patient to additional radiation. This also streamlines interpretation, because prior comparison studies are essential for detecting interval change.
Radiation dose tracking has moved from an academic concern to a regulatory and practical one. The Joint Commission has issued sentinel event alerts related to radiation overdose in imaging. Several states now require facilities to track cumulative radiation dose, and the Image Gently and Image Wisely campaigns have raised public awareness of radiation risk from medical imaging. Your intake form should ask about recent CT scans, fluoroscopic procedures, nuclear medicine studies, and radiation therapy, with enough specificity that your department can make informed decisions about protocol optimization. If a patient has had four CT scans of the abdomen in the last year, the radiologist may choose a lower-dose protocol, substitute an MRI or ultrasound if clinically appropriate, or at minimum document the clinical justification for the additional radiation exposure.
For pediatric patients, dose tracking is especially important because children are more radiosensitive than adults and have more remaining years of life in which radiation-induced cancers could manifest. Pediatric radiology intake forms should capture all prior imaging, and the department should have protocols in place to apply size-specific dose estimates and to use pediatric-appropriate technique factors rather than defaulting to adult protocols.
Claustrophobia assessment and sedation screening
MRI-related claustrophobia is not a minor inconvenience that patients should simply endure. It is a clinical reality that affects between five and fifteen percent of patients referred for MRI, depending on how broadly the term is defined, and it directly impacts scan quality and completion rates. A patient who panics mid-scan and moves or requests early termination produces non-diagnostic images, wastes the scanner time slot, and still needs the clinical information that the MRI was ordered to provide. The result is a rescheduled exam, often with sedation, which adds cost, procedural risk, and delay.
Your intake form should assess claustrophobia before the patient arrives for their appointment so that accommodations can be arranged in advance. The assessment should go beyond a yes-or-no question. Ask whether the patient has had a prior MRI and, if so, whether they completed it without difficulty. Ask whether the patient experiences anxiety in enclosed spaces such as elevators, tunnels, or small rooms. Ask whether the patient has previously required sedation or anxiolytic medication for any medical procedure. This information allows the scheduling staff to assign claustrophobic patients to an open or wide-bore MRI system if one is available, to schedule additional time for the appointment to allow for coaching and breaks, or to arrange for conscious sedation with appropriate pre-procedure fasting and monitoring.
If your department offers sedation for MRI, the intake form must also capture sedation screening information: nothing-by-mouth status, body weight for dosing calculations, current medications that may interact with sedatives, a history of adverse reactions to sedation or anesthesia, sleep apnea or other airway concerns, and whether the patient has arranged for a driver to take them home afterward. Sedation screening for MRI is substantively the same as pre-procedural sedation screening in any other setting, and it carries the same medicolegal documentation requirements.
Exam-specific preparation instructions and compliance verification
Many imaging studies require patient preparation that must be completed before the patient arrives, and the intake form is the mechanism for verifying that the preparation was actually done. A patient who arrives for an abdominal ultrasound having eaten breakfast two hours ago cannot be scanned, because a contracted gallbladder and bowel gas from digestion will obscure the relevant anatomy. The appointment must be rescheduled, the scanner sits idle, and the department absorbs the lost revenue. All of this is preventable if preparation instructions are communicated clearly at the time of scheduling and verified on the intake form at the time of arrival.
The preparation requirements vary substantially by modality and exam type. Abdominal and pelvic ultrasound typically requires a period of fasting, usually six to eight hours for upper abdominal studies, and a full bladder for pelvic imaging. CT colonography, sometimes called virtual colonoscopy, requires full bowel preparation comparable to an optical colonoscopy, including a clear-liquid diet, cathartic agents, and often oral contrast tagging agents the day before the exam. Breast MRI should ideally be scheduled during days seven through fourteen of the menstrual cycle in premenopausal women because hormonal fluctuations outside this window can cause background parenchymal enhancement that reduces diagnostic accuracy. Nuclear medicine studies involving the thyroid require discontinuation of certain medications, most notably amiodarone, and avoidance of iodine-containing foods and supplements for a specified period before the exam.
Your intake form should include a preparation compliance section for each major exam type, structured as a series of verification questions that the patient or the front-desk staff completes at check-in. Did the patient fast for the required period? Did the patient complete the bowel preparation? Is the patient currently on her menstrual cycle, and if so, what day? Has the patient discontinued the specified medication? Did the patient remove all jewelry and body piercings? For MRI patients specifically: did the patient remove hearing aids, dentures with metal components, hair clips, underwire bras, transdermal medication patches (which can contain metallic foil backing that heats in the MRI), and any other removable metallic items?
The preparation verification serves a dual purpose. It prevents wasted appointments and scan time when the patient is not adequately prepared, and it creates a documented record that the department fulfilled its obligation to instruct and verify. If a patient claims they were not told to fast, and the intake form shows a signed acknowledgment of fasting instructions, the department has evidence of compliant practice.
Referring physician documentation and medical necessity
Every imaging study requires a referring physician's order that includes a clinical indication sufficient to establish medical necessity. This is both a regulatory requirement under CMS guidelines and a practical necessity for insurance authorization. Your intake form should capture the referring physician's name, practice, NPI number, phone and fax, and the clinical indication as stated on the order. The clinical indication matters enormously for two reasons that go beyond billing.
First, the radiologist uses the clinical indication to tailor the imaging protocol. A CT of the abdomen ordered for "abdominal pain" will be protocoled differently than one ordered for "staging of known pancreatic adenocarcinoma." The first may be a standard portal-venous phase study. The second requires a dual-phase pancreas protocol with thin-section arterial and venous phases to evaluate vascular involvement. If the clinical indication is vague or missing on the order and your intake process does not clarify it, the radiologist either protocols the study generically and potentially misses the relevant pathology, or delays the study to call the referring physician, which disrupts the schedule for every patient behind this one.
Second, insurance denials for imaging studies increasingly turn on documentation of medical necessity. Prior authorization is now required for many advanced imaging studies, including most MRI and CT examinations, under CMS and commercial payer policies. The Protecting Access to Medicare Act mandated clinical decision support consultation for advanced imaging orders beginning in 2020, and enforcement with payment penalties has been phased in. Your intake process should capture whether prior authorization has been obtained, the authorization number, and the approved procedure code. If authorization is pending or denied, the department needs to know before the patient is prepped and positioned, not after the scan has already been performed and the claim is rejected.
For patients with workers' compensation or personal injury claims, the documentation requirements are even more specific. The intake form should capture the claim number, date of injury, employer or insurance carrier, and adjuster contact information. Billing errors on workers' compensation imaging claims are common and expensive to correct, and the information needed to bill correctly is most efficiently captured at intake rather than reconstructed after the fact.
Equipment limitations: weight capacity and bore dimensions
This is a sensitive but clinically and operationally necessary section of the radiology intake form. MRI tables have weight limits, typically between 350 and 550 pounds depending on the system, and the bore diameter of a standard closed MRI is approximately 60 centimeters, though wide-bore systems at 70 centimeters are increasingly common. CT scanners have similar weight limits for the table, and the gantry aperture, while larger than an MRI bore, still has dimensional constraints. Interventional fluoroscopy tables have weight limits that may be lower than diagnostic tables because they incorporate tilting mechanisms.
Your intake form should capture the patient's weight so the department can verify that the requested study can be performed safely on the available equipment. If the patient exceeds the table weight limit of your standard MRI, the department needs to know this at scheduling, not when the patient arrives for their appointment, so that the exam can be scheduled on a system with a higher weight capacity or referred to a facility that has one. Attempting to scan a patient who exceeds the table weight limit risks equipment damage and patient injury, and turning a patient away at the time of their appointment because of equipment limitations that should have been anticipated is a patient experience failure that could have been prevented by a single question on the intake form.
The form should address this with clinical neutrality. A weight field is standard on any medical intake form and does not need special framing. If your department has specific equipment limitations, the scheduling staff can use the intake information to assign the patient to the appropriate scanner without the patient needing to know that this was a factor in the scheduling decision.
Insulin pumps, glucose monitors, and wearable medical devices
The proliferation of wearable medical devices has added a new category of MRI safety concern that did not exist a decade ago and that many intake forms have not yet been updated to address. Insulin pumps, continuous glucose monitors, and patch-style medication delivery devices are now worn by millions of patients, and most of these devices must be removed before entering the MRI suite because they contain metallic components, electronic circuitry, or both.
Insulin pumps are particularly high-stakes because removal affects the patient's glucose management. The patient needs advance notice to plan for pump removal, and the department needs to know how long the patient will be disconnected from their pump so that the endocrinologist or the patient themselves can adjust their insulin regimen accordingly. A patient on an insulin pump who is not warned to bring their backup injection supplies may face a dangerous gap in insulin delivery during a long MRI study. Your intake form should ask about insulin pump use, the pump manufacturer and model, and whether the patient has been instructed to remove the device and bring alternative insulin delivery supplies.
Continuous glucose monitors, such as the Dexterity G7, FreeStyle Libre, and Medtronic Guardian systems, must also be removed before MRI. These devices are adhesive-mounted and typically worn for ten to fourteen days, and removal means the patient loses the remaining sensor life and must apply a new sensor after the scan. Some patients are reluctant to remove these devices because of the cost and inconvenience, and technologists occasionally report patients who deny having a CGM when asked verbally but who are found to be wearing one during the metal-detection screening. The intake form should ask about CGMs specifically by name and category, not rely on a generic "do you have any medical devices" question that patients may not connect to a small adhesive patch on their upper arm.
Transdermal medication patches are another category that requires explicit screening. Some patches, including certain fentanyl, nicotine, and nitroglycerin patches, contain metallic foil backing that can heat during MRI and cause skin burns. The intake form should ask about transdermal patches so the technologist can verify the specific brand and determine whether removal is necessary. In some cases, the patch can be replaced after the scan, but the patient and their prescribing physician need to be involved in that decision.
Interventional radiology: separate consent and sedation requirements
Interventional radiology procedures, including image-guided biopsies, drain placements, angioplasty, embolization, port placements, and vertebroplasty, carry procedural risks that go well beyond those of diagnostic imaging and require a separate layer of intake documentation. The intake form for an interventional procedure must capture everything required for a diagnostic study, plus a complete pre-procedural assessment comparable to what would be obtained before a surgical procedure.
Medication history takes on additional specificity for interventional procedures. Anticoagulant and antiplatelet medications must be identified, and the patient must be asked whether they have received instructions about holding these medications before the procedure. A patient on warfarin who has not been instructed to hold it, or who held it but has not had a same-day INR drawn to confirm adequate reversal, cannot safely undergo a biopsy or drain placement. Similarly, patients on direct oral anticoagulants such as apixaban, rivarelbán, or dabigatran need specific hold instructions based on the drug's half-life and the bleeding risk of the planned procedure. Your intake form should capture the anticoagulant name, last dose taken, and whether hold instructions were provided and followed.
Sedation screening for interventional procedures follows the same requirements as procedural sedation in any setting. The intake form must capture the patient's NPO status, American Society of Anesthesiologists physical status classification, airway assessment, history of adverse reactions to anesthesia or sedation, current medications including MAO inhibitors and other drugs that interact with sedation agents, obstructive sleep apnea status, body weight for dosing calculations, and whether the patient has a responsible adult available to drive them home. For procedures performed under general anesthesia, the anesthesia team will conduct their own pre-anesthesia assessment, but the radiology intake form should capture enough information to identify patients who may require anesthesia rather than moderate sedation so that arrangements can be made in advance.
Informed consent documentation for interventional procedures is separate from the imaging consent and must include a discussion of the specific risks of the planned procedure, alternative approaches, and the expected recovery course. While the consent conversation itself is conducted by the interventional radiologist, the intake form should verify that consent has been obtained and documented before the patient is brought into the procedure room.
Building a radiology intake process that actually protects patients
The throughput pressure in a modern imaging center is real. MRI scanners cost millions of dollars and generate revenue only when they are running, which creates a structural incentive to minimize anything that slows patient flow. But the intake form is not a bottleneck to be optimized away. It is the safety system that prevents the catastrophic events that end careers, close practices, and injure patients. Every question on the form exists because somewhere, at some point, a patient was harmed because that question was not asked.
The best radiology intake forms are structured so that the safety-critical questions, the MRI screening, the contrast allergy history, the pregnancy status, cannot be skipped or left blank. They are designed so that a positive answer to any red-flag question automatically triggers a workflow: a page to the MRI safety officer, a call to the referring physician, a delay for premedication, a referral to an open MRI. The form is not just a document that gets filed in the chart. It is an active component of the department's safety infrastructure, and it works only if it captures the right information, from every patient, every time.
A thorough intake process also protects the department in ways that go beyond patient safety. Documentation of screening, preparation verification, and informed consent creates the evidentiary record that the department needs in the event of an adverse outcome, a malpractice claim, or a regulatory investigation. The question is never whether you can afford the time to do intake properly. The question is whether you can afford the consequences of not doing it.
Streamline Your Radiology Intake Process
Fillable PDF intake forms and client questionnaires designed for radiology and imaging centers. MRI safety screening, contrast media history, pregnancy verification, exam preparation compliance, sedation assessment, and HIPAA documentation — built for the workflows that imaging centers actually run.
Browse All Forms View BundlesNot ready to buy? Download our free Universal Intake Form — a fillable PDF you can use today, no purchase needed.